Navigation Links
Haemonetics Reports Third Quarter of Fiscal 11
Date:1/31/2011

ition of in-process research and development.  We establish our budgets, forecasts, and performance targets excluding these costs.Non-GAAP Operating Income and Non-GAAP Income before Income Taxes
The use of these non-GAAP measures allows management to monitor the level of operating and total pre-tax profits without the costs of our business transformation.  We establish our budgets, forecasts, and performance targets on this basis.Non-GAAP Net Income and Earnings per Share
The use of these non-GAAP measures allows management to monitor the level of net income and earnings per share excluding both the costs of our business transformation, as well as any related tax effects. We establish our budgets, forecasts, and performance targets on this basis.Reconciliation of Non-GAAP Measures for the Third Quarter of FY11 and FY1001/01/1112/26/09Non-GAAP gross profitGAAP gross profit$93,490$85,447Restructuring costs--Non-GAAP gross profit$93,490$85,447Non-GAAP S,G&AGAAP S,G&A$56,935$53,151Restructuring, deal integration and closing costs(3,735)(450)Non-GAAP S,G&A$53,200$52,701Non-GAAP operating expensesGAAP operating expenses$64,931$59,612Restructuring, deal integration and closing costs(3,735)(450)Non-GAAP operating expenses$61,196$59,162Non-GAAP operating income GAAP operating income$28,559$25,835Restructuring, deal integration and closing costs3,735450Non-GAAP operating income $32,294$26,285Non-GAAP income before taxesGAAP income before taxes$27,974$25,377Restructuring, deal integration and closing costs3,735450Non-GAAP income before taxes$31,709$25,827Non-GAAP net incomeGAAP net income$19,734$18,286Restructuring, deal integration and closing costs3,735450Tax benefit associated with non-GAAP items(873)(110)Non-GAAP net income$22,596$18,626Non-GAAP net income per common share assuming dilutionGAAP net income per common share assuming dilution$0.77$0.71Non-GAAP items after tax per common share assuming dilution$0.12$0.01Non-GAAP net income
'/>"/>
SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology
2. Neogen Reports 33% Increase in Net Income
3. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
4. New Topical Patent Research Reports Recently Published at MarketPublishers.com
5. YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387
6. Oncothyreon Reports Positive Data from Phase 1 Clinical Trial of PI3-Kinase Inhibitor PX-866 in Patients with Relapsed or Refractory Solid Tumors
7. GeneLink Reports Third Quarter Results
8. Imagenetix, Inc. Reports Second Quarter 2011 Results
9. Transgenomic Reports Third Quarter Financial Results
10. Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... and Champaign, IL (PRWEB) April 20, 2015 ... the establishment of its 12th clinical research site: PMG ... Research has assumed operation of the clinical research department ... PMG’s footprint outside the Southeast to a second region ... a 150 multi-specialty physician practice enhances PMG’s access to ...
(Date:4/20/2015)... April 20, 2015  Eli Lilly and Company (NYSE: ... several targeted cancer therapies, reflecting Lilly,s diverse oncology pipeline, ... Meeting 2015, held April 18-22 in Philadelphia ... to Patients" is the theme of this year,s AACR ... to broadening its portfolio of therapies that accelerate the ...
(Date:4/20/2015)... 20, 2015 Sinovac Biotech Ltd. (Nasdaq: SVA), ... announced its unaudited financial results for the fourth quarter ... Fourth Quarter 2014 Financial Highlights(Compared to the fourth quarter ... a decrease of 11.4% from $22.9 million in the ... of H5N1 pandemic influenza vaccine of $0.1 million in ...
(Date:4/18/2015)... , April 18, 2015 ... CRIS ) will be presenting data at ... American Associate of Cancer Research Annual Meeting (April ...      (Logo: http://photos.prnewswire.com/prnh/20130418/608115 ) , ... proprietary Nicotinamide phosphoribosyltransferase (NAMPT) small molecule inhibitors program, ...
Breaking Biology Technology:PMG Research Announces the Formation of its 12th Site in Champaign-Urbana, IL 2PMG Research Announces the Formation of its 12th Site in Champaign-Urbana, IL 3Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 2Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 3Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18Aurigene to Present its NAMPT and IRAK-4 Inhibitors Programs at AACR 2015 2
... announced they have entered into a research collaboration to improve insect ... ... Iowa and Research Triangle Park, NC (Vocus) January 15, 2009 -– ... collaboration to improve insect control in corn and soybeans. Under ...
... DIEGO, Jan. 15 BioMed Realty Trust, Inc. (NYSE: ... two lease extensions in Cambridge, Massachusetts with Vertex Pharmaceuticals ... Erie Street (also known as Vertex,s Corporate Headquarters at ... leases now extend through December 31, 2015. In total, ...
... Follow-up Exam on First Patient to Receive Preventive ... Pa., Jan. 15 The first patient receiving ... a 6-month follow-up examination that revealed successful stabilization ... led by Professor Patrick W. Serruys, MD, PhD, ...
Cached Biology Technology:DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 2DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 3BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015 2BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015 3vProtect(TM) Luminal Shield Stabilizes Life-Threatening Plaque 2
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, the ... users across iOS and Android ... integrating biofeedback into the platform to allow patients to ... For the first time, patients will be able to ... dose impacts important biometrics, such as glucose levels and ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/26/2015)... TORONTO , March 26, 2015 ... premier family, social, recreation and athletic club, today announced ... designed to allow freedom of movement for members and ... "Following a comprehensive process, we selected FST,s IMID ... sophistication and convenience for our members and staff, in ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... Researchers at the Salk Institute have been able to genetically ... into neural stem cells, which then differentiate into brain neurons ... new technique, described in the June 16 online issue of ... of many different kinds of stem cells in humans as ...
... An NIH-funded network of researchers will evaluate ... on reproduction and birth outcomes, the cardiorespiratory system, ... community and university partnerships, under the leadership of ... will conduct research to evaluate the level of ...
... of Life Sciences discovered four new species of jewel ... is named for their particularly beautiful body and fascinating, ... genus Philanthaxia . Before the publication of this ... Currently, it comprises of 65 species, with a primarily ...
Cached Biology News:'Unnatural' chemical allows Salk researchers to watch protein action in brain cells 2'Unnatural' chemical allows Salk researchers to watch protein action in brain cells 3NIH-funded research network to explore oil spill health effects 2
Porcine Aortic Endothelial Cells (PAOEC) (>500,000 cells)...
alpha-N-Catenin Antibody Shipping Temperature: HOT Storage Temperature: -20C...
... Chain MAP1A and MAP1B are microtubule-associated proteins ... components of the cytoskeleton. MAP1A and MAP1B each ... light chain subunits. The protein encoded by this ... and can associate with either MAP1A or MAP1B. ...
... SM22 alpha, also known as smooth muscle cell ... high levels in various tissues such as intestine, ... the regulatory protein, calponin. SM22 alpha expression has ... muscle in both vascular and visceral forms. It ...
Biology Products: